all patients , who participated in a phase iii trial ( n = 110 ) , had disseminated disease and received first line endocrine treatment of either orchidectomy or a monthly injection of a depot luteinizing hormone-releasing hormone analogue ( zoladex ) .
C0014136
endocrine
C0029189
orchidectomy